Health and Wellness
The FDA claims the wearable tech company's BPI offering is "adulterated" and "misbranded," and is being sold without the proper regulatory approvals.
Hippocratic AI will integrate its generative AI agents to support triage and patient intake.
Patients will have 24/7 access to personalized speech, language and cognitive therapies.
The company will use the funds to augment key content partnerships.
The company will use the funds to move into the female health space and increase screening and preventive care.
The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.
The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.
It can also predict the onset of Parkinson's motor symptoms.
Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization.
Also, NSW Health launches its latest virtual menopause health hub in southwestern Sydney.